Trinity Biotech's Trinovium unit signs cooling deal with Red Team Investments
The contract covers a U.S. pilot supplying liquid cooling fluids and analytical systems for AI and high-performance computing data centers.
SEC filing
Latest
6 stories
Wednesday, September 9
Friday, August 28
Trinity Biotech faces Nasdaq delisting risk, updates diagnostics transformation
Trinity Biotech will request a Nasdaq hearing after failing to regain compliance with the exchange's market value requirement by August 18, 2026, while reporting progress across its diagnostics pipeline.
SEC filing
Monday, August 17
Trinity Biotech's Trinovium unit partners with Echelon on AI data center cooling
The collaboration, announced August 17, 2026, will pair Trinovium's fluid technology with Echelon's hyperscale data center infrastructure to develop liquid cooling systems for AI computing.
SEC filing
Friday, August 14
Trinity Biotech gets $7.0 million from Perceptive, regains Nasdaq bid price compliance
The Dublin-based diagnostics company disclosed the funding amendment and Nasdaq notice in a 6-K dated August 14, 2026.
SEC filing
Wednesday, July 22
Trinity Biotech to implement 30-for-1 ADS ratio change
The company said the move is meant to help regain Nasdaq compliance and widen its potential investor base.
SEC filing
Trinity Biotech and Latch Medical partner on biosensor-guided drug delivery
Trinity Biotech plans an equity investment in Latch Medical as the two companies explore linking Trinity's CGM+ biosensor with Latch's intradermal delivery device.
SEC filing